Feed - News and features

• UK approves Novo Nordisk's Wegovy pill
  Novo Nordisk's fast-growing Wegovy...
• Takeda's TYK2 drug bests BMS's Sotyktu in psoriasis contest
  New data with Takeda's TYK2 inhibitor...
• J&J adds rare disease wAIHA to Imaavy's potential uses
  Johnson & Johnson's 'Swiss army...
• Novartis gets win for another Avidity muscular dystrophy AOC
  Novartis' $12bn takeover of Avidity...

News | PharmaTimes

• NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
• Anocca doses first patients with precision TCR‑T therapy
• Connecta launches phase 2a trial of neuroplasticity modulator
• Aquipta recommended by NICE for acute migraine treatment
• Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma

• A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer
• Digital Support for Multiple Myeloma Quality of Life
• Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
• AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)